PHP

Parkman Healthcare Partners Portfolio holdings

AUM $864M
1-Year Est. Return 33.7%
This Quarter Est. Return
1 Year Est. Return
+33.7%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$864M
AUM Growth
+$21.2M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
103
New
Increased
Reduced
Closed

Top Buys

1 +$17.3M
2 +$16.2M
3 +$9.25M
4
DXCM icon
DexCom
DXCM
+$8.34M
5
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$7.63M

Top Sells

1 +$27.6M
2 +$26.3M
3 +$10.8M
4
GILD icon
Gilead Sciences
GILD
+$9.68M
5
THC icon
Tenet Healthcare
THC
+$7.84M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CVS icon
1
CVS Health
CVS
$104B
$35.7M 4.11%
517,807
+21,071
PODD icon
2
Insulet
PODD
$22.9B
$33.2M 3.82%
105,762
-24,752
BSX icon
3
Boston Scientific
BSX
$151B
$30.4M 3.5%
283,166
+57,176
ALNY icon
4
Alnylam Pharmaceuticals
ALNY
$62.8B
$30.1M 3.46%
92,338
+23,400
THC icon
5
Tenet Healthcare
THC
$18.9B
$29.7M 3.42%
168,884
-44,534
COO icon
6
Cooper Companies
COO
$14.5B
$27.4M 3.15%
385,479
+72,829
LLY icon
7
Eli Lilly
LLY
$737B
$26M 2.98%
33,296
-5,895
QGEN icon
8
Qiagen
QGEN
$10.5B
$23.9M 2.75%
498,107
+138,463
ZBH icon
9
Zimmer Biomet
ZBH
$20.4B
$21.9M 2.52%
240,395
+39,895
DHR icon
10
Danaher
DHR
$156B
$21.7M 2.5%
110,090
+46,840
NBIX icon
11
Neurocrine Biosciences
NBIX
$14.7B
$20.9M 2.4%
166,010
-2,372
SYK icon
12
Stryker
SYK
$146B
$19.9M 2.29%
50,376
-27,314
DXCM icon
13
DexCom
DXCM
$27.6B
$19.7M 2.27%
225,875
+95,508
EW icon
14
Edwards Lifesciences
EW
$44.4B
$19.7M 2.26%
251,741
+50,922
VRNA
15
DELISTED
Verona Pharma
VRNA
$18.7M 2.15%
197,898
-62,523
VRDN icon
16
Viridian Therapeutics
VRDN
$2.11B
$18.2M 2.09%
1,298,825
+234,319
IQV icon
17
IQVIA
IQV
$37.1B
$17.3M 1.98%
+109,500
WGS icon
18
GeneDx Holdings
WGS
$3.78B
$16.2M 1.86%
+175,000
RVTY icon
19
Revvity
RVTY
$11.1B
$15.2M 1.75%
157,196
+17,639
GILD icon
20
Gilead Sciences
GILD
$149B
$14.6M 1.68%
131,675
-87,275
KNSA icon
21
Kiniksa Pharmaceuticals
KNSA
$3B
$13.5M 1.55%
488,796
-273,825
MCK icon
22
McKesson
MCK
$100B
$12.8M 1.47%
17,458
-4,643
BMRN icon
23
BioMarin Pharmaceuticals
BMRN
$10.5B
$12.4M 1.42%
225,150
-52,102
TVTX icon
24
Travere Therapeutics
TVTX
$2.61B
$12.2M 1.41%
827,060
-127,011
SDGR icon
25
Schrodinger
SDGR
$1.64B
$11.8M 1.36%
587,556
+106,086